The role of clinical guidelines in reducing the burden of cardiovascular diseases.
https://doi.org/10.23946/2500-0764-2025-10-2-15-31
Abstract
Aim. To assess the impact of implementing evidencebased cardiology guidelines into the clinical practice in the Russian Federation and selected European countries on trends in cardiovascular disease (CVD) mortality. Materials and Methods. Mortality data were obtained from the Global Burden of Disease database. Countries were grouped into five clusters based on CVD mortality rates. Information on implemented clinical guidelines was gathered from professional society websites and published national and international sources. We further conduced an epidemiological analysis of CVD mortality before and after the implementation of clinical guidelines, including before-after analysis of mortality trends. Results. After the implementation of clinical cardiology guidelines, a reduction in CVD mortality was observed in Spain, Estonia, Russia, Latvia, Belarus, Ukraine, and especially United Kingdom and the Netherlands. Decrease in mortality in Belgium, France, Slovakia, Italy, Portugal, Germany, and the Czech Republic was associated with successful CVD prevention campaigns and active use of clinical cardiology guidelines in clinical practice. Increased mortality in Croatia, Serbia, Bosnia and Herzegovina, Lithuania, Romania, and Bulgaria was linked to limited economic resources that hindered full implementation of preventive and treatment programs. Conclusion. The integration of CVD clinical guidelines into the national healthcare systems has played a significant role in reducing mortality. Achieving the full potential of CG implementation requires a comprehensive strategy that ensures access to quality care for the entire population, including preventive and rehabilitation programs, sufficient funding, modern infrastructure, and continuous professional development of healthcare personnel. Systemic integration of guideline-based prevention, diagnostics, and treatment can further reduce CVD morbidity and mortality
About the Authors
R. V. Polibin
Sechenov First Moscow State Medical University (Sechenov University)
Russian Federation
Russian Federation
Dr. Roman V. Polibin, MD, Cand. Sci. (Medicine), Chief Scientific Officer, Erismann Institute of Public Health; Associate Professor, Department of Epidemiology and Evidence-based Medicine
Trubetskaya Street, 8, Building 2, Moscow, 119048
I. V. Petukhova
Sechenov First Moscow State Medical University (Sechenov University)
Russian Federation
Russian Federation
Dr. Irina V. Petukhova, MD, Clinical Resident, Department of Epidemiology and Evidence-Based Medicine
Trubetskaya Street, 8, Building 2, Moscow, 119048
References
1. Kosolapov VP, Yarmonova MV. The analysis of high cardiovascular morbidity and mortality in the adult population as a medical and social problem and the search for ways to solve it. Ural Medical Journal. 2021;20(1):58–64. (In Russ.). https://doi.org/10.52420/2071-5943-2021-20-1-58-64
2. Roth GA, Mensah GA, Johnson CO, Addolorato G, Ammirati E, Baddour LM et al. Global Burden of Cardiovascular Diseases and Risk Factors, 1990-2019: Update From the GBD 2019 Study. J Am Coll Cardiol. 2020;76(25):2982–3021. https://doi.org/10.1016/j.jacc.2020.11.010
3. Pyorala K, De Backer G, Graham I, Poole-Wilson P, Wood D. Prevention of coronary heart disease in clinical practice: recommendations of the task force of the European Society of cardiology, European atherosclerosis Society and European society of Hypertension. Atherosclerosis. 1994;110(2):121–161. https://doi.org/10.1016/0021-9150(94)90200-3
4. Prevention of coronary heart disease in clinical practice: Recommendations of the Second Joint Task Force of European and other Societies on Coronary Prevention. Eur Heart J. 1998;19(10):1434– 1503. https://doi.org/10.1053/euhj.1998.1243
5. De Backer G, Ambrosioni E, Borch-Johnsen K, Brotons C, Cifkova R, Dallongeville J, et al. European guidelines on cardiovascular disease prevention in clinical practice; Third Joint Task Force of European and other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of eight societies and by invited experts). Eur J Cardiovasc Prev Rehabil. 2003;10(4):S1-S10.https://doi.org/10.1097/01.hjr.0000087913.96265.e2
6. Graham I, Atar D, Borch-Johnsen K, Boysen G, Burell G, Cifkova R, et al. European guidelines on cardiovascular disease prevention in clinical practice: executive summary: Fourth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (Constituted by representatives of nine societies and by invited experts). Eur Heart J. 2007;28(19):2375–2414. https://doi.org/10.1093/eurheartj/ehm316
7. Perk J, De Backer G, Gohlke H, Graham I, Reiner Z, Verschuren M et al. European Guidelines on cardiovascular disease prevention in clinical practice (version 2012). The Fifth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of nine societies and by invited experts). Eur Heart J. 2012;33(13):1635–1701. https://doi.org/10.1093/eurheartj/ehs092
8. Piepoli MF, Hoes AW, Agewall S, Albus C, Brotons C, Catapano АL, et al. Linee guida europee 2016 sulla prevenzione delle malattie cardiovascolari nella pratica clinica. Sesta Task Force congiunta della Società Europea di Cardiologia e di altre Società sulla Prevenzione delle Malattie Cardiovascolari nella Pratica Clinica (costituita da rappresentanti di 10 società e da esperti invitati). Redatte con il contributo straordinario dell’Associazione Europea per la Prevenzione e Riabilitazione Cardiovascolare (EACPR). G Ital Cardiol. 2017;18(7):547–612. https://doi.org/10.1714/2729.27821
9. Visseren FLJ, Mach F, Smulders YM, Carballo D, Koskinas KC, Bäck M, et al. 2021 ESC Guidelines on cardiovascular disease prevention in clinical practice. Eur Heart J. 2021;42(34):3227–3337. https://doi.org/10.1093/eurheartj/ehab484
10. European Society of Hypertension-European Society of Cardiology Guidelines Committee. 2003 European Society of Hypertension-European Society of Cardiology guidelines for the management of arterial hypertension. J Hypertens. 2003;21(6):1011–1053. https://doi.org/10.1097/00004872-200306000-00001
11. Mancia G, De Backer G, Dominiczak A, Cifkova R, Fagard R, Germano G, et al. 2007 Guidelines for the management of arterial hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). Eur Heart J. 2007;28(12):1462–1536. https://doi.org/10.1093/eurheartj/ehm236
12. Mancia G, Fagard R, Narkiewicz K, Redon J, Zanchetti A, Böhm M, et al. 2013 ESH/ESC guidelines for the management of arterial hypertension: the Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). Eur Heart J. 2013;34(28):2159–219. https://doi.org/10.1093/eurheartj/eht151
13. Williams B, Mancia G, Spiering W, Agabiti Rosei E, Azizi M, Burnier M, et al. 2018 ESC/ESH Guidelines for the management of arterial hypertension. Eur Heart J. 2018;39(33):3021–3104. https://doi.org/10.1093/eurheartj/ehy339
14. Mancia G, Kreutz R, Brunström M, Burnier M, Grassi G, Januszewicz A, et al. 2023 ESH Guidelines for the management of arterial hypertension The Task Force for the management of arterial hypertension of the European Society of Hypertension: Endorsed by the International Society of Hypertension (ISH) and the European Renal Association (ERA). J Hypertens. 2023;41(12):1874–2071. https://doi.org/10.1097/HJH.0000000000003480
15. Treating mild hypertension. Report of the British Hypertension Society working party. BMJ. 1989;298(6675):694–698. https://doi.org/10.1136/bmj.298.6675.694
16. Sever P, Beevers G, Bulpitt C, Lever A, Ramsay L, Reid J, et al. Management guidelines in essential hypertension: report of the second working party of the British Hypertension Society. BMJ. 1993;306(6883):983–987. https://doi.org/10.1136/bmj.306.6883.983
17. Ramsay L, Williams B, Johnston G, MacGregor G, Poston L, Potter J et al. Guidelines for management of hypertension: report of the third working party of the British Hypertension Society. J Hum Hypertens. 1999;13(9):569–592. https://doi.org/10.1038/sj.jhh.1000917
18. Williams B, Poulter NR, Brown MJ, Davis M, McInnes GT, Potter JF et al. Guidelines for management of hypertension: report of the fourth working party of the British Hypertension Society, 2004-BHS IV. J Hum Hypertens. 2004;18(3):139–185. https://doi.org/10.1038/sj.jhh.1001683
19. OECD/European Observatory on Health Systems and Policies. Czech Republic: Country Health Profile 2017, State of Health in the EU. OECD Publishing, Paris/European Observatory on Health Systems and Policies, Brussels; 2017. http://dx.doi.org/10.1787/9789264283336-en
20. Hagemeister J, Schneider CA, Barabas S, Schadt R, Wassmer G, Mager G et al. Hypertension guidelines and their limitations--the impact of physicians' compliance as evaluated by guideline awareness. J Hypertens. 2001;19(11):2079–2086. https://doi.org/10.1097/00004872-200111000-00020
21. Predel HG, Graas F, Rudinger G, Randerath O. Management of arterial hypertension: Transfer from clinical guidelines into daily practice – Results of a survey in German practitioners offices. J Educ Health Promot. 2020;9:34. https://doi.org/10.4103/jehp.jehp_426_19
22. Donfrancesco C, Noce CL, Lonardo AD, Vannucchi S, Palmieri L. Progetto CUORE: health examination survey e studi longitudinali a supporto della prevenzione cardiovascolare. Boll Epidemiol Naz. 2021;2(4):12-21. https://doi.org/10.53225/BEN_032
23. OECD, European Observatory on Health Systems and Policies. Portugal: Country Health Profile 2023. State of Health in the EU. OECD Publishing, Paris/European Observatory on Health Systems and Policies, Brussels; 2023. https://doi.org/10.1787/069af7b1-en
24. Pilav A, Brankovic S, Doder V. Ten Year Trends in Cardiovascular Risk Factors in the Federation of Bosnia and Herzegovina. Med Arch. 2014;68(6):394–398. https://doi.org/10.5455/medarh.2014.68.394-398
25. Fazlibegović E, Terzić I, Hadziomerovic M. Current uses of ISACSTC registry in Mostar. Int J Cardiol. 2016;217:S44–S46. https://doi.org/10.1016/j.ijcard.2016.06.224
26. Ramic-Catak A, Mesihovic-Dinarevic S, Prnjavorac B, Naser N, Masic I. Public Health Dimensions of Cardiovascular Diseases (CVD) Prevention and Control – Global Perspectives and Current Situation in the Federation of Bosnia and Herzegovina. Mater Socio-Medica. 2023;35(2):88–93. https://doi.org/10.5455/msm.2023.35.88-93
27. Pilav A, Nissinen A, Haukkala A, Nikšić D, Laatikainen T. Cardiovascular Risk Factors in the Federation of Bosnia and Herzegovina. Eur J Public Health. 2007;17(1):75–79. https://doi.org/10.1093/eurpub/ckl066
28. Vlajinac H, Sipetic S, Saulic A, Atanackovic Z, Marinković J, Bjegovic V. Burden of ischaemic heart disease and cerebrovascular diseases in Serbia without Kosovo and Metohia, 2000. Eur J Cardiovasc Prev Rehabil. 2006;13(5):753–759. https://doi.org/10.1097/01.hjr.0000238395.04600.b5
29. Laucevičius A, Kasiulevičius V, Jatužis D, Petrulioniene Z. Lithuanian High Cardiovascular Risk (LitHiR) primary prevention programme - rationale and design. Semin Cardiovasc Med. 2012;18(1):1-6. https://doi.org/10.2478/v10287-012-0003-3
30. Simionescu M, Bilan S, Gavurova B, Bordea EN. Health Policies in Romania to Reduce the Mortality Caused by Cardiovascular Diseases. Int J Environ Res Public Health. 2019;16(17):3080. https://doi.org/10.3390/ijerph16173080
31. OECD, European Observatory on Health Systems and Policies. Lietuva: 2023 m. Sveikatos Būklės Šalyje Apžvalga, State of Health in the EU. OECD Publishing, Paris/European Observatory on Health Systems and Policies, Brussels; 2023. https://doi.org/10.1787/5ed683c8-en.
Review
For citations:
Polibin R.V., Petukhova I.V. The role of clinical guidelines in reducing the burden of cardiovascular diseases. Fundamental and Clinical Medicine. 2025;10(2):15-31. (In Russ.) https://doi.org/10.23946/2500-0764-2025-10-2-15-31
Views:
42
Email this article 